President & Chief Executive Officer
Michael May completed his PhD in Chemical Engineering at the University of Toronto in 1998 as a NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship.
Michael is currently the President and Chief Executive Officer of CCRM. Prior to CCRM, Michael was the President, Chief Operating Officer and co-founder of Rimon Therapeutics Ltd., a Toronto-based regenerative medicine company developing novel medical polymers that possess drug-like activity. Michael sits on a number of Boards and advisory committees, including: MaRS Innovation, 20/20 Vision, the Ontario Institute for Regenerative Medicine (OIRM), the Advanced Regenerative Tissue Engineering Centre, ExCellThera Ltd., the Alliance for Regenerative Medicine (ARM), the Department of Chemical Engineering and Applied Chemistry at the University of Toronto, the Cell and Gene Therapy Insights Editorial Advisory Board, and many more.